Fast Track designation granted for CDX-110 for the treatment of glioblastoma multiforme.
- Published in:
- Expert Review of Pharmacoeconomics & Outcomes Research, 2008, v. 8, n. 1, p. 6
- Publication type:
- Article
Works matching DE "CELLDEX Therapeutics Inc."
Results: 3
1
2
CDX-301: a novel medical countermeasure for hematopoietic acute radiation syndrome in mice.
- Published in:
- Scientific Reports, 2020, v. 10, n. 1, p. 1, doi. 10.1038/s41598-020-58186-1
- By:
- Publication type:
- Article
3
Fact Track designation granted for CDX-110 for the treatment of glioblastoma multiforme.
- Published in:
- Expert Review of Neurotherapeutics, 2008, v. 8, n. 2, p. 178
- Publication type:
- Article